Table 3.
Specificity, sensitivity, PPV and NPV of CT-based markers (FLP and SAH) against CAA diagnosis according to pathology (A; n = 16), MRI (B; N = 11) and Pathology or MRI (C; n = 16; of which 11 had MRI)
Specificity | Sensitivity | PPV | NPV | Accuracy | |
---|---|---|---|---|---|
A | |||||
FLP | 44% | 71% | 50% | 67% | 56% |
SAH | 44% | 100% | 58% | 100% | 69% |
FLP or SAH | 22% | 100% | 50% | 100% | 56% |
FLP and SAH | 67% | 71% | 63% | 75% | 69% |
B | |||||
FLP | 50% | 67% | 33% | 80% | 55% |
SAH | 38% | 100% | 38% | 100% | 55% |
C | |||||
FLP | 43% | 67% | 60% | 50% | 56% |
SAH | 57% | 100% | 75% | 100% | 81% |
FLP or SAH | 29% | 100% | 64% | 100% | 69% |
FLP and SAH | 71% | 67% | 75% | 63% | 69% |